Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02561819 · ClinicalTrials.gov registry record

Measurement of Body Composition by Air Displacement Plethysmography in Pediatric Intestinal Failure Patients

A clinical trial of Short Bowel Syndrome, sponsored by Christopher Duggan.

Completed
Registry status
25
Enrollment target
1
Study location

NCT02561819: Completed study of Short Bowel Syndrome, sponsored by Christopher Duggan.

NCT02561819 is a study of Short Bowel Syndrome that has completed, run by Christopher Duggan. The registered enrollment target is 25 participants, below the 183-participant average among 17 other Short Bowel Syndrome trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02561819, a study of Short Bowel Syndrome, has completed, sponsored by Christopher Duggan.

COMPLETED
Registry status
25 participants
Enrollment target
1
Study location

Study Summary

This study will determine if air-displacement plethysmography (ADP) provides accurate measurement of body composition (percent body fat and fat-free mass) in pediatric patients with intestinal failure, as compared to body composition measured by alternative standard methods, including deuterium dilution, bioimpedance analysis (BIA), dual x-ray absorptiometry (DXA) when clinically indicated, and routine anthropometric measurements.

Primary Outcome

Body composition (percent body fat and fat-free mass) as measured by air displacement plethysmography in pediatric patients with intestinal failure will be compared to body composition measurements done by the deuterium dilution technique, DXA scan, and bioimpedance analysis.

Conditions Studied

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2015-11
Est. Completion 2020-12
Christopher Duggan

1 total trials

What the finished NCT02561819 record still lists

NCT02561819 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 183-participant average among 17 other Short Bowel Syndrome trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Short Bowel Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT02561819 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02561819 about?

NCT02561819 is a clinical study titled "Measurement of Body Composition by Air Displacement Plethysmography in Pediatric Intestinal Failure Patients". This study will determine if air-displacement plethysmography (ADP) provides accurate measurement of body composition (percent body fat and fat-free mass) in pediatric patients with intestinal failure, as compared to body composition measured by alternative standard methods, including deuterium dilu...

What is the current status of trial NCT02561819?

This trial is currently completed. The enrollment target is 25 participants. The study started on 2015-11. Estimated completion is 2020-12.

What conditions does trial NCT02561819 study?

This clinical trial studies the following conditions: Short Bowel Syndrome.

Who is sponsoring clinical trial NCT02561819?

This trial is sponsored by Christopher Duggan, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02561819 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Short Bowel Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02561819's enrollment target sits among peer trials

25 15th of 17 higher than 3 of 17 other Short Bowel Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Short Bowel Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02561819, the US trial registry maintained by the National Library of Medicine. NCT02561819 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.